Stephen G Swisher Selected Research

Stephen G Swisher Research Topics

Disease

133	Neoplasms (Cancer) 11/2022 - 01/2002
63	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2003
57	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2002
52	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2002
46	Adenocarcinoma 11/2021 - 12/2004
27	Carcinoma (Carcinomatosis) 10/2022 - 04/2003
25	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2002
8	Malignant Mesothelioma 01/2022 - 05/2005
8	Pathologic Complete Response 01/2021 - 12/2005
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 12/2004
5	Infections 02/2018 - 08/2005
5	Melanoma (Melanoma, Malignant) 05/2005 - 04/2002
4	Pneumonia (Pneumonitis) 01/2021 - 03/2008
4	Colorectal Neoplasms (Colorectal Cancer) 05/2020 - 12/2012
4	Carcinogenesis 01/2019 - 01/2011
4	Breast Neoplasms (Breast Cancer) 08/2011 - 02/2002
3	Hemorrhage 01/2021 - 12/2017
3	Disease Progression 01/2021 - 11/2014
3	Leukemia 11/2017 - 01/2015
3	Anastomotic Leak 04/2014 - 01/2002
3	Sarcoma (Soft Tissue Sarcoma) 05/2011 - 11/2005
3	Barrett Esophagus (Barrett's Esophagus) 12/2009 - 02/2007
2	Esophageal Squamous Cell Carcinoma 12/2022 - 02/2007
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 02/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2020 - 12/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2020
2	Lymphatic Metastasis 01/2020 - 02/2012
2	Adenocarcinoma of Lung 01/2019 - 12/2013
2	Wounds and Injuries (Trauma) 11/2016 - 02/2002

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2008
19	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
12	eIF-2 Kinase (eIF 2 Kinase)IBA 01/2020 - 04/2002
7	PlatinumIBA 02/2018 - 05/2005
6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2018
6	Pharmaceutical PreparationsIBA 01/2021 - 05/2005
6	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2005 - 04/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2010
5	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2004
4	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2017
4	Biological ProductsIBA 01/2020 - 03/2008
4	ParaffinIBA 01/2018 - 04/2009
4	1- ((3- chlorophenyl)methyl)- 1H- indole- 3- carbinolIBA 11/2017 - 05/2012
4	ErbB Receptors (EGF Receptor)IBA 07/2015 - 02/2007
4	E2F1 Transcription FactorIBA 03/2010 - 04/2003
3	Hematoxylin (Haematoxylon)IBA 11/2021 - 01/2007
3	Eosine Yellowish-(YS) (Eosin)IBA 11/2021 - 01/2007
3	Oxygen (Dioxygen)IBA 09/2021 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2006
3	Indicators and Reagents (Reagents)IBA 08/2020 - 09/2006
3	CytokinesIBA 01/2020 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2009
3	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 03/2006
3	LigandsIBA 01/2018 - 01/2017
3	Formaldehyde (Formol)FDA Link 01/2018 - 04/2009
3	Messenger RNA (mRNA)IBA 01/2018 - 09/2009
3	AntigensIBA 01/2017 - 11/2007
3	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 05/2012
3	Cyclin D1IBA 01/2011 - 02/2007
3	InterferonsIBA 02/2009 - 02/2002
3	LuciferasesIBA 08/2005 - 04/2003
2	NivolumabIBA 11/2022 - 01/2021
2	IpilimumabIBA 11/2022 - 01/2021
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2022 - 06/2006
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2020
2	Dasatinib (BMS 354825)FDA Link 10/2020 - 12/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2020 - 10/2004
2	B7-H1 AntigenIBA 01/2020 - 01/2019
2	Therapeutic UsesIBA 01/2020 - 01/2017
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2018
2	Capecitabine (Xeloda)FDA Link 11/2019 - 01/2017
2	NucleotidesIBA 01/2019 - 01/2019
2	EnzymesIBA 01/2019 - 01/2013
2	Thioredoxin-Disulfide ReductaseIBA 01/2019 - 01/2019
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 02/2009
2	Glutathione (Reduced Glutathione)IBA 01/2019 - 01/2019
2	Auranofin (Ridaura)FDA Link 01/2019 - 01/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018 - 09/2014
2	AntibodiesIBA 01/2017 - 03/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 08/2005
2	taxaneIBA 01/2017 - 12/2003
2	Histones (Histone)IBA 01/2017 - 12/2009

Therapy/Procedure

99	Therapeutics 12/2022 - 01/2002
34	Radiotherapy 10/2020 - 01/2002
31	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
31	Neoadjuvant Therapy 01/2022 - 02/2002
26	Chemoradiotherapy 11/2019 - 09/2003
22	Esophagectomy 12/2022 - 01/2002
12	Induction Chemotherapy 01/2019 - 09/2003
9	Immunotherapy 01/2021 - 02/2002
6	Aftercare (After-Treatment) 10/2022 - 10/2017
6	Pneumonectomy (Lung Volume Reduction) 01/2022 - 03/2004
6	Metastasectomy 09/2019 - 09/2009
6	Length of Stay 01/2018 - 01/2002
4	Proton Therapy 10/2020 - 08/2011
3	Thoracotomy 09/2020 - 05/2010
3	Operative Surgical Procedures 01/2020 - 12/2003
3	Adjuvant Chemotherapy 01/2019 - 07/2010
2	Precision Medicine 05/2020 - 07/2015
2	Stents 01/2020 - 12/2017
2	Perioperative Period 02/2018 - 09/2002